Anika Therapeutics (ANIK) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Anika Therapeutics (ANIK) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 32.23% |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | -16.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.11% |
| Mar 31, 2026 | -19.87% |
| Dec 31, 2025 | -12.68% |
| Sep 30, 2025 | -12.91% |
| Jun 30, 2025 | -16.52% |
| Mar 31, 2025 | -16.09% |
| Dec 31, 2024 | -16.16% |
| Sep 30, 2024 | -11.83% |
| Jun 30, 2024 | -13.53% |
| Mar 31, 2024 | -10.15% |
| Dec 31, 2023 | -10.48% |
| Sep 30, 2023 | -12.15% |
| Jun 30, 2023 | -17.70% |
| Mar 31, 2023 | 6.60% |
| Dec 31, 2022 | -18.16% |
| Sep 30, 2022 | -5.31% |
| Jun 30, 2022 | 9.61% |
| Mar 31, 2022 | -1.84% |
| Dec 31, 2021 | 1.96% |
| Sep 30, 2021 | 3.60% |